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SUmmARy – Chemical peels are growing in popularity with new agents, formulas and met-
hods giving them greater reliability and safety. Although the operative procedure may seem rela-
tively simple, proper knowledge and skills of the physician and education of the patient is crucial. 
it is very important for the physician to know chemical structure of the peels, level of necrosis they 
make in the skin, indications, absolute and relative contraindications, side effects and complications. 
it is also very important to evaluate the patients, their needs and their expectations, and to present 
them objective possibilities of the procedure. in chemical peels and their efficacy, preoperative and 
postoperative care plays an important role, which is out of the reach of the physician and therefore 
should be emphasized in consultation with the patient. 
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Introduction
Chemical peeling, according to historical data, 
was first practiced in ancient egypt, where people 
used chemexfoliation methods to rejuvenate skin. The 
original chemexfoliant was lactic acid, an active in-
gredient of sour milk that was used topically by the 
nobles as part of an ancient skin rejuvenation regi-
men. in ancient Rome, old wine with tartaric acid as 
its active ingredient was used for the same purpose. 
Today, these historical chemexfoliants are known to 
contain alpha hydroxy acids. modern chemical peel-
ing was originally promoted by dermatologists such 
as P.g. Unna, who first described the properties of 
salicylic acid, resorcinol, phenol, and trichloroacetic 
acid (TCA). Slowly, the early practitioners of chemi-
cal peels began to develop other peeling agents for 
varying depths of penetration. in the 1960s, Baker 
and gordon developed a deep peeling agent, which 
was able to smooth deeper furrows, especially around 
the mouth1.
Chemical peeling is accelerated exfoliation or skin 
damage induced by caustic agents that cause controlled 
damage, resulting in thickening of the epidermis, de-
position of collagen, reorganization of structural ele-
ments, and increase in dermal volume. This process 
decreases solar elastosis. The result is an improved 
clinical appearance of the skin, with fewer rhytides 
and decreased pigmentary dyschromia2,3.
Chemical peelings can be divided into three cat-
egories. According to the histological level of necrosis, 
they cause4:
1. very superficial (exfoliation) – destruction of stra-
tum corneum without creating a wound below the 
stratum granulosum;
2. superficial (epidermal) – destruction of part of or 
all epidermis; anywhere from stratum granulosom 
to basal layer;
3. medium (papillary, dermal) – destruction of epider-
mis and part of dermis (to upper reticular dermis); 
and
4. deep (reticular dermis) – destruction of epidermis 
and dermis (into reticular dermis). 
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This classification helps predict which skin ab-
normalities will be corrected by a particular chemical 
peeling according to the histological level of peel. 
The most commonly used superficial, medium and 
deep peelings are5: 
1. very superficial – glycolic acid 30%-50% (applied 
for 1 to 2 min), Jessner solution (applied in 1 or 
2 coats), low concentration resorcinol (20%-30%) 
applied briefly, TCA 10% (applied in 1 coat)
2. superficial peels - resorcinol, 40%-50% applied for 
30 to 60 minutes; and TCA, 10%-30%.
3. medium-depth agents include the following: gly-
colic acid 70% applied for a variable time (3 to 30 
minutes); TCA, 35%-50%; and augmented TCA 
(carbon dioxide plus TCA 35%; Jessner solu-
tion plus TCA 35%; glycolic acid 70% plus TCA 
35%)6.
4. deep agents include the following: phenol 88% 
and Baker-gordon phenol formula7.
Healing Process
The healing process after a chemical peel must be 
as rapid as possible to avoid infections that may deep-
en the wounds, extending the peel from superficial to 
deep, with an increased risk of scarring. 
Production of controlled chemical burns of the 
epidermis and/or dermis results in exfoliation. The 
first phases of this process must be understood well 
to control the depth of penetration of chemical peel-
ings.
Phases are as follows:
1. development of diffuse homogeneous erythema 
indicates epidermal penetration.
2. development of white frost indicates coagulative 
necrosis of the papillary dermis.
3. development of gray-white frost indicates coagu-
lative necrosis of the reticular dermis.
evaluation of the patient by the clinician is nec-
essary to determine appropriate treatment based on 
dermal defect. when evaluating the patient before 
the peel, extensive history should be taken. if it is 
determined that chemical peel is warranted, appro-
priate agent is chosen based on the patient’s Fitzpat-
rick skin type and glogau photoaging group, as well 
as other variables that may affect peel penetration. 
The patient should be educated about the chemical 
peel process and give a signed consent in case of me-
dium or deep peel. The patient has to be questioned 
about his/her general health status, medications (e.g., 
oral isotretinoin), smoking, previous cosmetic proce-
dures (e.g., surgical lifts, fluid silicone injections), re-
current herpetic outbreaks, and keloid formation.












•	 Acne vulgaris – mild to moderate acne
Aesthetic 
•	 Photoaging









•	 dermatosis papulosa nigra
Relative contraindications
Relative contraindications are determined by the pa-
tient’s skin type and the defect being treated. To optimize 
the procedure, some classifications are very useful, such 
as Fitzpatrick and glogau photoaging classifications. 
Fitzpatrick skin typing is graded 1-6, with the first 
3 skin types being white skin with a progressively 
more active response to tanning8. Type 4 is light-
brown skin, and type 5 is dark brown skin. Type 6 
skin never tans and is essentially black skin with an 
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equivalent sun protective factor (SPF) of 8. Fitzpat-
rick skin types 5 and 6 are usually not ideal candi-
dates for medium and deep peels. The best candi-
dates are the light skin types 1, 2 and 3, which are 
at a lower risk of complications such as pigment dy-
schromia and scarring. Although skin types 5 and 6 
are not ideal for peels, they can be peeled using su-
perficial agents such as salicylic acid or glycolic acid. 
glogau photoaging classification is a visual grad-
ing system used to quantify photodamage9. Patients 
with photoaging type i are not good candidates for 
deep peeling because the peel may be more damag-
ing than beneficial, while a superficial peel would be 
more efficacious. Patients with type iV photodamage 
may benefit from deep peeling, while a superficial peel 
may not make much of a difference. Patients with skin 
types ii and iii ordinarily benefit from superficial or 
medium-depth peels, depending on the exact circum-
stances of the patient. Other variables should also be 
considered, including the Fitzpatrick skin type, when 
determining which peeling agent to use.
Absolute Contraindications
•	 Active bacterial, viral, fungal, or herpetic infec-
tion
•	 Open wounds
•	 History of drugs with photosensitizing potential
•	 Preexisting inflammatory dermatoses (e.g., psoria-
sis, atopic dermatitis)
•	 Uncooperative patient (patient is careless about 
sun exposure or application of medicine)
•	 Patient with unrealistic expectations
•	 For medium-depth and deep peels, history of 
abnormal scarring, keloids, atrophic skin, or isot-
retinoin use in the last 6 months10.
Instructions and Consent
A detailed consent form listing details about the 
procedure and possible complications should be signed 
by the patient11. The consent form should specifically 
state the limitations of the procedure and should clear-
ly mention if more procedures are needed for proper 
results. The patient should be provided with an oppor-
tunity to seek information through brochures, presen-
tations, and personal discussions. The need of post-
operative medical therapy should be emphasized12. 
Following the peel, the patient must follow the instruc-
tions given by the physician to prevent complications. 
if possible, the patient should stay out of the sun; when 
unavoidable, the patient should apply a strong sun-
screen and wear a hat. An ointment such as petroleum 
jelly or bacitracin should be applied to the involved skin. 
The patient should be made aware that the skin will 
exfoliate and may look cosmetically unattractive for a 
period of time, depending on the depth of the peel. 
For superficial peels, a follow-up appointment can be 
scheduled at the time of the next peel. For deeper peels, 
patients should be seen 2-3 times a week following the 
peel to provide for early intervention if problems develop. 
The patient should be instructed to remain vigilant for 
signs of infection. if the patient has a history of cold 
sores, treating the patient with acyclovir (400 mg PO 
bid) or an equivalent antiviral therapy, is mandatory.
Complications
Scarring remains the most dreaded complication 
of chemical peels. The contributing factors are not 
well understood. By matching the patient and peeling 
agent properly, the risk of scarring can be decreased. 
in addition, to further decrease the risk of scarring, 
the patient should be advised to refrain from picking 
at the healing skin. Pigmentary changes are not un-
common complication, especially with deeper peeling 
agents. Patients with lighter complexion have a lower 
risk of hyperpigmentation, but genetic factors play an 
important role. A combination of hydroquinone and 
tretinoin cream (Kligman formulation) before a su-
perficial or medium-depth peel and early introduction 
of this preparation after deep peels reduces the rate of 
this complication13. infections are relatively uncom-
mon. herpes simplex infection can be prevented with 
acyclovir (400 mg PO bid), beginning 2 days prior to 
the peel and continuing for 7 days after it. The most 
important potential complication of deep peels is car-
diotoxicity14. The complications also include prolonged 
erythema (longer than 90 days) that can be cured with 
local application of corticosteroids, acne that usually 
develops between days 3 and 9, and milia that usually 
appear 2-3 weeks after re-epithelialization. 
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Sažetak
KemiJSKi PilinZi – KAdA i ZAŠTO?
L. Oremović, Ž. Bolanča i M. Šitum
Kemijski pilinzi zauzimaju sve značajnije mjesto u estetskoj kozmetologiji. Velikom zanimanju za ove zahvate dopri-
nosi visoka učinkovitost, relativna jednostavnost postupka, dostupnost, relativno malo nuspojava i komplikacija. Kako bi 
se postigao što bolji učinak kemijskog pilinga potrebna je obostrana angažiranost klijenta i liječnika. liječnik treba znati 
sve o kemijskoj podlozi pilinga, stupnju nekroze koji pojedini piling izaziva u koži, indikacijama i kontraindikacijama te 
nuspojavama i komplikacijama. Prilikom prijeoperacijskih konzultacija važno je dobro procijenti klijenta, ne samo vrstu 
njegove kože već i njegova očekivanja od samoga postuka te ga upoznati s objektivnim mogućnostima istoga. Također je 
važno naglasiti i značenje prijeoperacijske i poslijeoperacijske njege, što je isključivo u rukama klijenta.
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